TITLE
Sarah Kanbour: Clinical Update - Navigating Discontinuation of Wegovy®, Ozempic®, and Mounjaro® Before Surgery
TALK INFO
Surgeons are increasingly encountering patients on Wegovy®, Ozempic®, and Mounjaro®—but how should these medications be managed before surgery? Join us for this essential clinical update:
Understand the latest guidelines on preoperative GLP-1 agonist management
Learn to minimize aspiration and delayed gastric emptying risks
Improve surgical safety and optimize patient outcomes
Practical, evidence-based insights tailored for the OR
You can watch the first 8 minutes for free.
CLINICAL PATHWAY
Medical Assess and Management
SPEAKER
DATE
16/02/26
LEARNING OBJECTIVES
After participating in this educational activity, learners will be able to:
Explain the pharmacology and mechanisms of action of GLP-1 receptor agonists relevant to surgical and anesthetic risk.
Recognize the perioperative implications of delayed gastric emptying and its impact on airway and aspiration risk.
Apply current guidelines and evidence-based recommendations for discontinuing GLP-1 medications prior to procedures involving sedation or general anesthesia.
Develop individualized preoperative management plans for patients on semaglutide (Ozempic®, Wegovy®) or tirzepatide (Mounjaro®) in collaboration with surgical and anesthesia teams.
Communicate effectively with interdisciplinary teams to ensure patient safety and optimize outcomes in the perioperative period.
ABOUT THE SPEAKER
Sarah Kanbour MD, MPH, is a double board-certified endocrinologist with specialized expertise in obesity pharmacotherapy, GLP-1 receptor agonist management, and perioperative risk reduction. As the use of medications like Wegovy®, Ozempic®, and Mounjaro® grows, her clinical and academic work focuses on guiding surgical teams in managing these therapies safely around the time of procedures—particularly those involving the airway, head and neck, or gastrointestinal tract.
Dr. Kanbour earned her Doctor of Medicine (MD) from Weill Cornell Medicine – Qatar, completed her residency in Internal Medicine at NewYork-Presbyterian/Weill Cornell Medical Center, and pursued fellowship training in Endocrinology, Diabetes, and Metabolism at the prestigious Johns Hopkins School of Medicine. She also holds a Master of Public Health (MPH) with a focus on medication safety and population health.
She is board-certified in:
Endocrinology, Diabetes & Metabolism – American Board of Internal Medicine
Internal Medicine – American Board of Internal Medicine
Dr. Kanbour is a nationally recognized educator and speaker, known for her ability to translate evolving evidence into practical, multidisciplinary protocols for use by surgeons, anesthesiologists, dentists, and perioperative care teams.
CE ACCREDITATION
surgeOn is an ADA CERP Recognized Provider. ADA CERP is a service of the American Dental Association to assist dental professionals in identifying quality providers of continuing dental education. ADA CERP does not approve or endorse individual courses or instructors, nor does it imply acceptance of credit hours by boards of dentistry. surgeOn designates this activity for 1 credit hour of continuing education credits.
This event may also be accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) for a maximum of 1 European CME credits (ECMEC®s). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. If you are a learner based in the U.S. or Canada EACCME credits are recognized by the American Medical Association (AMA) and the Royal College of Physicians and Surgeons of Canada.
DECLARATION
In accordance with criterion 13 of document UEMS 2023.07.rev “EACCME® Criteria for the Accreditation of Live Educational Events (LEEs)” and the Standard v. Commercial or Promotional Conflict of Interest, published by the American Dental Association Continuing Education Recognition Program (ADA CERP), all surgeON presenters sign a Conflict of Interest form to document all perceived or actual conflicts of interest for the last 3 years, whether due to a financial or other relationship. This document can be viewed at the beginning of the event or on request by emailing info@surgeon-events.org No fee, honorarium or arrangement for re-imbursement of expenses in relation to the this event has been provided to the speaker.
